Health and Healthcare

Amgen : AMGN

All Amgen Articles

707 Articles

Chris Lange | May 12, 2015 at 8:05 AM EDT

Short Sellers Start to Get Nervous on Biotech

The short interest data are out for the April 30 settlement date, and for most of the selected biotech stocks,…

Chris Lange | Apr 27, 2015 at 8:30 AM EDT

Short Sellers Become More Wary of Big Biotech

The short interest data are out for the April 15 settlement date. 24/7 Wall St. has reviewed the top biotech…

Lee Jackson | Apr 25, 2015 at 9:10 AM EDT

Massive Energy Trade Highlights High-Profile Insider Selling This Week

While the volume for insider trading has dropped dramatically due to earnings reporting, some very large trades hit the tape…

Lee Jackson | Apr 23, 2015 at 10:30 AM EDT

3 Top Stocks to Buy That Delivered Great Earnings

A new research report from Cowen features three top stocks of companies that exceeded earnings estimates that the firm feels…

Jon C. Ogg | Apr 23, 2015 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Barrick, Facebook, Halcon, Qualcomm, Synchrony, Texas Instruments and More

Thursday's top analyst upgrades, downgrades and initiations include Barrick Gold, Facebook, Halcon Resources, Qualcomm, Synchrony Financial and Texas Instruments.

Paul Ausick | Apr 21, 2015 at 4:29 PM EDT

Amgen Earnings Point to More Froth in the Biotech Sector

Amgen reported better-than-expected first-quarter 2015 earnings Tuesday afternoon after equity markets had closed.

Paul Ausick | Apr 21, 2015 at 11:35 AM EDT

Will Amgen Earnings Shape Biotech for the Rest of 2015?

After markets close on Tuesday, Amgen, the second-largest biotech, is scheduled to announce its first-quarter results.

Chris Lange | Apr 13, 2015 at 8:35 AM EDT

Short Sellers Increase Their Bets Against Biotech Stocks

The March 31 short interest data have been compared with the March 13 figures, and for most of the selected…

Jon C. Ogg | Apr 7, 2015 at 3:27 PM EDT

Goldman Sachs Cheapest Stocks, 6 Best Sector By Sector

Jon OggIf there is one firm on Wall Street that investors have been told that they want to pay attention to…

Chris Lange | Apr 6, 2015 at 12:45 PM EDT

Is a Big Share Buyback Coming to DaVita?

DaVita Healthcare Partners has a large amount of cash on its balance sheet and it does not pay a dividend.…

Lee Jackson | Mar 16, 2015 at 8:15 AM EDT

3 Leading Biotech Stocks Releasing Potential Catalyst Data This Week

One thing that can always drive a biotech stock higher is positive clinical data, and this week some big-time biotech…

Chris Lange | Mar 11, 2015 at 9:15 AM EDT

Short Sellers Get More Aggressive on Big Biotech

24/7 Wall St. has reviewed the top biotech companies, and the February 27 short interest data have been compared with…

Chris Lange | Feb 26, 2015 at 9:25 AM EST

Short Sellers Increase Bets Against Biotech as Shares Continue to Rise

The short interest data are out for the February 13 settlement date. 24/7 Wall St. has reviewed the top biotech…

Lee Jackson | Feb 18, 2015 at 8:25 AM EST

Analyst’s 4 Blue-Chip Biotech Stocks to Buy for the Rest of 2015

Here are the four top biotech stocks to buy now according to Deutsche Bank. These leaders have established drugs, solid…

Chris Lange | Feb 11, 2015 at 9:40 AM EST

Short Sellers Look Scared of Big Biotech

The short interest data are out for the January 30 settlement date. 24/7 Wall St. has reviewed the top biotech…

1 … 26 27 28 29 30 … 48

Amgen : AMGN

All Amgen Articles

Short Sellers Start to Get Nervous on Biotech

Short Sellers Become More Wary of Big Biotech

Massive Energy Trade Highlights High-Profile Insider Selling This Week

3 Top Stocks to Buy That Delivered Great Earnings

Top Analyst Upgrades and Downgrades: Barrick, Facebook, Halcon, Qualcomm, Synchrony, Texas Instruments and More

Amgen Earnings Point to More Froth in the Biotech Sector

Will Amgen Earnings Shape Biotech for the Rest of 2015?

Short Sellers Increase Their Bets Against Biotech Stocks

Goldman Sachs Cheapest Stocks, 6 Best Sector By Sector

Is a Big Share Buyback Coming to DaVita?

3 Leading Biotech Stocks Releasing Potential Catalyst Data This Week

Short Sellers Get More Aggressive on Big Biotech

Short Sellers Increase Bets Against Biotech as Shares Continue to Rise

Analyst’s 4 Blue-Chip Biotech Stocks to Buy for the Rest of 2015

Short Sellers Look Scared of Big Biotech

The Roth Conversion Window That Closes Faster Than Most 401(k) Savers Expect

NLR Trades at 0.61%: Why This Nuclear Fund Beats Uranium Miners

Tom Lee’s ‘Granny Shots’ ETF Is Beating the S&P Again, and He’s Calling for 8,000

The Roth Conversion Window That Closes Faster Than Most 401(k) Savers Expect

If You Just Inherited an IRA, Read This

The Roth Conversion Window That Closes Faster Than Most 401(k) Savers Expect

NLR Trades at 0.61%: Why This Nuclear Fund Beats Uranium Miners

Amgen : AMGN

All Amgen Articles

Short Sellers Start to Get Nervous on Biotech

Short Sellers Become More Wary of Big Biotech

Massive Energy Trade Highlights High-Profile Insider Selling This Week

3 Top Stocks to Buy That Delivered Great Earnings

Top Analyst Upgrades and Downgrades: Barrick, Facebook, Halcon, Qualcomm, Synchrony, Texas Instruments and More

Amgen Earnings Point to More Froth in the Biotech Sector

Will Amgen Earnings Shape Biotech for the Rest of 2015?

Short Sellers Increase Their Bets Against Biotech Stocks

Goldman Sachs Cheapest Stocks, 6 Best Sector By Sector

Is a Big Share Buyback Coming to DaVita?

3 Leading Biotech Stocks Releasing Potential Catalyst Data This Week

Short Sellers Get More Aggressive on Big Biotech

Short Sellers Increase Bets Against Biotech as Shares Continue to Rise

Analyst’s 4 Blue-Chip Biotech Stocks to Buy for the Rest of 2015

Short Sellers Look Scared of Big Biotech

The Roth Conversion Window That Closes Faster Than Most 401(k) Savers Expect

NLR Trades at 0.61%: Why This Nuclear Fund Beats Uranium Miners

Tom Lee’s ‘Granny Shots’ ETF Is Beating the S&P Again, and He’s Calling for 8,000

Featured Reads

The Roth Conversion Window That Closes Faster Than Most 401(k) Savers Expect

If You Just Inherited an IRA, Read This